Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1980-7-22
pubmed:abstractText
The protease inhibitor leupeptin inhibits the degradation process of (125)I-labeled epidermal growth factor ((125)I-EGF) by cultured bovine granulosa cells. At 80 mug/ml, leupeptin inhibited the appearance of degradation products of (125)I-EGF in the medium by 95% during 1 hr of incubation and by 90% during 24 hr of incubation when the cells were exposed to 5 ng of (125)I-EGF per ml. In contrast, cultures exposed to either saturating (10 ng/ml) or nonsaturating (0.1 ng/ml) concentrations of EGF in the presence of leupeptin (80 mug/ml) exhibited an increase in DNA synthesis that was 70-80% that of cultures exposed to EGF alone. Cultures responded to either EGF or fibroblast growth factor with a logarithmic increase in cell number and, over a period of 8 days, the number of cells increased 10- to 18-fold. Addition of leupeptin did not diminish the growth rate of the cultures. In the presence of leupeptin, (125)I-EGF accumulated within the granulosa cells and was in a form that was precipitable with antiserum against EGF and that comigrated on isoelectric focusing with native (125)I-EGF. That a full mitogenic response can be obtained despite a 90-95% inhibition of EGF degradation at either saturating or nonsaturating concentrations of the mitogen suggests that a proteolytic degradation of a given mitogen may not be involved in the induction of a proliferative response.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-1012021, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-1054489, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-14450081, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-215996, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-220539, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-226968, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-23215, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-300054, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-306387, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-307248, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-307249, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-311281, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-313931, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-4636326, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-5012739, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-649600, http://linkedlifedata.com/resource/pubmed/commentcorrection/6966398-977646
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1466-70
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
Role of the degradation process in the mitogenic effect of epidermal growth factor.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.